MME MARIE-PIERRE LOUIS

Rhumatologue

RPPS 10000944867

✨ Génération du profil synthétique IA en cours…

Lieu de consultation

Tarifs & secteur de conventionnement

Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).

📊 Comprendre le remboursement

Prendre rendez-vous & contact

🗓 Trouver sur Doctolib 📇 Ajouter à mes contacts

Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.

Top publications · les plus citées

Growth Factors Levels Determine Efficacy of Platelets Rich Plasma Injection in Knee Osteoarthritis: A Randomized Double Blind Noninferiority Trial Compared With Viscosupplementation

Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association · 2018

📚 98 citations🎯 RCR 6.39Top 5% NIH🩺 Clinique

Lire l'abstract Crossref ↓

Purpose To assess the noninferiority of a single platelet‐rich plasma (PRP) injection compared with hyaluronic acid (HA), to alleviate pain and enhance functional capacity in knee osteoarthritis, and identify biological characteristics of PRP that may affect their efficacy. Methods Fifty‐four patients with symptomatic knee osteoarthritis received a single injection of either PRP (26 patients) or HA (28 patients). They were assessed at baseline and at 1, 3, and 6 months. The primary endpoint was the change in Western Ontario and McMaster Universities Arthritis Index (WOMAC) score at 3 months, and secondary endpoints were responders' rate (improvement of at least 5 points or 40% of WOMAC total score at 3 months) of pain evaluation and patient's subjective satisfaction. Cell counts and the contents of vascular endothelial growth factor (VEGF), platelet‐derived growth factor–AB (PDGF‐AB), transforming growth factor beta 1 (TGF‐β1) content of injected PRP were assessed to analyze their relationship with clinical outcome. Results Both treatments proved their improvement in knee functional status and symptom relief, with a significant decrease observed at 1 month on all scores except for pain VAS in PRP group and WOMAC function score in the HA group. No difference between groups regarding WOMAC and VAS scores was observed. A higher percentage of responders was observed in the PRP group (72.7%) than in the HA group (45.8%) without significance ( P = .064). The quantity of injected PDGF‐AB and TGF‐β1 correlated with the change in WOMAC scores at 3 months and was lower in responders than in nonresponders ( P = .009 and P = .003, respectively). Conclusions Current results indicated that a single injection of very pure PRP offers a significant clinical improvement in the management of knee osteoarthritis, equivalent to a single HA injection in this patient population. Moreover, a significant correlation between the doses of TGF‐β1 and PDGF‐AB and the worsening of WOMAC score 3 months after the procedure was found. Level of Evidence Level II, randomized double blind controlled trial.

Induction of autoantibodies during prolonged treatment with infliximab

The Journal of rheumatology · 2003

📚 58 citations🎯 RCR 1.87

Surgical management of type II tibial intercondylar eminence fractures in children

Journal of pediatric orthopedics. Part B · 2008

📚 27 citations🎯 RCR 1.55

Cookies & analyse de trafic

MME MARIE-PIERRE LOUIS

Pourquoi vous devez consulter ce praticien

Lieu de consultation

Tarifs & secteur de conventionnement

Prendre rendez-vous & contact

Top publications · les plus citées

Publications scientifiques (15) — classées par pathologie

Transversal6

Case report / série3

Essai clinique2

Gériatrie2

Anti-TNF1

Pédiatrie1

Revue générale1

Partager cette fiche